Interactions between the endocrine and exocrine pancreas and their clinical relevance

Pancreatology

Volumn 9, Issue 4, 2009, Pages 351-359

  Czakó, László ^a   Hegyi, Péter ^a   Rakonczay Jr , Zoltán ^a   Wittmann, Tibor ^a   Otsuki, Makoto ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chronic pancreatitis; Diet; Enzyme replacement therapy; Exocrine pancreatic function; Glucagon; Insulin; Insulin therapy; Pancreatic diabetes

Indexed keywords

BIGUANIDE DERIVATIVE; GLITAZONE DERIVATIVE; GLUCAGON; HORMONE; INSULIN; ORAL ANTIDIABETIC AGENT; PANCREAS ENZYME; STEROID;

ACUTE HEMORRHAGIC PANCREATITIS; AUTOIMMUNE PANCREATITIS; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; ENDOCRINE FUNCTION; ENDOCRINE GLAND; ENZYME REPLACEMENT; EXOCRINE GLAND; GLUCAGON RELEASE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MICROANGIOPATHY; MORTALITY; NONHUMAN; PANCREAS CANCER; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS RESECTION; PANCREATITIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STELLATE CELL; STEROID THERAPY; STREPTOZOCIN DIABETES;

EID: 66049112916     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000181169     Document Type: Review

References (72)

1. Owyang C: Endocrine changes in pancreatic insufficiency; in Go VLW, Di Magno EP (eds): The Pancreas: Biology, Pathobiology and Diseases. New York, Raven Press, 1993, pp 803-813.
2. Angelopoulos N, Dervenis C, Goula A, Rom-bopoulos G, Livadas S, Kaltsas D, Kaltzidou V, Tolis G: Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology 2005; 5: 122-131.
3. Koizumi M, Yoshida Y, Abe N, Shimosegawa T, Toyota T: Pancreatic diabetes in Japan. Pancreas 1998; 16:385-391.
4. Lévy P, Milan C, Pignon JP, Baetz A, Ber-nades P: Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients. Gastroenterology 1989; 96: 1165-1172.
5. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30:S42-S47.
6. Bank S, Marks IN, Vinik AI: Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 1975; 64: 13-22.
7. Ibars EP, Sanchez de Rojas EA, Quereda LA, Ramis RF, Sanjuan VM, Peris RT: Pancreatic function after acute biliary pancreatitis: does it change? World J Surg 2002; 26:479- 486.
8. Lankisch PG, Löhr-Hoppe A, Otto J, Creutzfeldt W: Natural course in chronic pancreatitis. Digestion 1993; 54: 148-155.
9. Larsen S: Diabetes mellitus secondary to chronic pa ncreatitis. Dan Med Bull 1993; 40: 153-162.
10. Cavallini G, Frulloni L, Pederzoli P, Talami-ni G, Bovo P, Bassi C, Di Francesco V, Vaona B, Falconi M, Sartori N, Angelini G, Brunori MP, Filippini M: Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol 1998; 33: 880-889.
11. Ito T, Otsuki M, Itoi T, Shimosegawa T, Fu-nakoshi A, Shiratori K, Naruse S, Kuroda Y; Research Committee of Intractable Diseases of the Pancreas: Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol 2007; 42:291-297.
12. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P: Risk factors of diabetes mellitus in chronic pancreatitis. Gastroenterology 2000; 119:1324-1332.
13. Okuno G, Oki A, Kawakami F, Doi K, Baba S: Prevalence and clinical features of diabetes mellitus secondary to chronic pancreatitis in Japan: a study by questionnaire. Diabet Res Clin Pract 1990; 10: 65-71.
14. Mohan V, Barman KK, Rajan VS, Chari ST, Deepa R: Natural history of endocrine failure in tropical chronic pancreatitis: a longitudinal follow-up study. J Gastroenterol Hepatol 2005; 20:1927-1934.
15. Olsen TS: The incidence and clinical relevance of chronic inflammation in the pancreas in autopsy material. Acta Pathol Mi-crobiol Scand A 1978; 86: 361-365.
16. Gröger G, Layer P: Exocrine pancreatic function in diabetes mellitus. Eur J Gastroent Hepatol 1995; 7:740-746.
17. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klör HU: Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin- dependent diabetes mellitus. Pancreatology 2002; 2: 30-33.
18. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J, Bretzel RG, Hol-lenhorst M, Kloer HU; S2453112/S2453113 Study Group: High prevalence of exocrine pancreatic insufficiency in diabetes melli-tus. A multicenter study screening fecal elas-tase-1 concentrations in 1,021 diabetic patients. Pancreatology 2003; 3:395-402.
19. Nakamura T, Imamura K, Takebe K, Terada A, Arai Y, Tandoh Y, Yamada N, Ishii M, Ma-chida K, Suda T: Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol 1996; 20:169-175.
20. Wittingen J, Frey CF: Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 1974; 179:412-414.
21. Trimble ER, Halban PA, Wollheim CB, Re-nold AE: Functional differences between rat islets of ventral and dorsal pancreatic origin. J Clin Invest 1982; 69: 405-413.
22. Büchler MW, Friess H, Müller MW, Wheat-ley AM, Beger HG: Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1995; 169: 65-70.
23. Izbicki JR, Bloechle C, Broering DC, Kuechler T, Broelsch CE: Longitudinal V-shaped excision of the ventral pancreas for small duct disease in severe chronic pancreatitis: prospective evaluation of a new surgical procedure. Ann Surg 1998; 227:213-219.
24. Aspelund G, Topazian MD, Lee JH, Andersen DK: Improved outcomes for benign disease with limited pancreatic head resection. J Gastrointest Surg 2005; 9: 400-409.
25. Sohn TA, Campbell KA, Pitt HA, Sauter PK, Coleman JA, Lillemo KD, Yeo CJ, Cameron JL: Quality of life and long-term survival after surgery for chronic pancreatitis. J Gastro-intest Surg 2000; 4:355-365.
26. Sokrafas GH, Farnell MB, Nagorney DM, Sarr MG, Rowland CM: Pancreatoduode-nectomy for chronic pancreatitis. Arch Surg 2000; 135: 517-524.
27. Sato N, Yamaguchi K, Yokohata K, Shimizu S, Noshiro H, Mizumoto K, Chijiiwa K, Tanaka M: Changes in pancreatic function after pancreatoduodenectomy. Am J Surg 1998; 176:59-61.
28. Witt H, Apte M V, Keim V, Wilson JS: Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007; 132:1557-1573.
29. Miyahara T, Kawabuchi M, Goto M, Nakano I, Nada O, Nawata H: Morphological study of pancreatic endocrine in an experimental chronic pancreatitis with diabetes induced by stress and cerulein. Ultrastruct Pathol 1999; 23: 171-180.
30. Goto M, Nakano I, Kimura T, Miyahara T, Kinjo M, Nawata H: New chronic pancreatitis model with diabetes induced by cerulean plus stress in rats. Dig Dis Sci 1995; 40: 2356- 2363.
31. Cavallini G, Vaona B, Bovo P, Cigolini M, Rigo L, Rossi F: Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci 1993; 38:497-501.
32. Andersen DK: Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas 2007; 35:1- 15.
33. Rossi L, Parvin S, Hassan Z, Hildebrand P, Keller U, Ali L, Beglinger C, Azad Khan AK, Whitcomb DC, Gyr N: Diabetes mellitus in tropical chronic pancreatitis is not just a secondary type of diabetes. Pancreatology 2004; 4: 461-467.
34. Vinik AI: Insulin secretion in chronic pancreatitis; in Tiengo A, Alberti KGMM, Del Prato S, Vranic M (eds): Diabetes Secondary to Pancreopathy. Amsterdam, Excerpta Medica, 1988, pp 33-50.
35. Diem P: Pathogenesis and treatment of diabetes secondary to chronic pancreatitis; in Büchler MW, Friess H, Uhl W, Malfertheiner P (eds): Chronic Pancreatitis. Novel Concepts in Biology and Therapy. Berlin, Black-well, 2002, pp 355-358.
36. Linde J, Nilsson LH, Barany FR: Diabetes and hypoglycemia in chronic pancreatitis. Scand J Gastroenterol 1977; 12: 369-373.
37. Sjoberg RJ, Kidd GS: Pancreatic diabetes mellitus. Diabetes Care 1989; 12:715-724.
38. Larsen S, Hilsted J, Philipsen EK, Tronier B, Christensen NJ, Damkjaer Nielsen M, Worn-ing H: Glucose counterregulation in diabetes secondary to chronic pancreatitis. Metabolism 1990; 39:138-143.
39. Keller U, Szöllösy E, Varga L, Gyr K: Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis. Dig Dis Sci 1984; 29:853-857.
40. Hedetoft C, Sheikh SP, Larsen S, Holst JJ: Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes melli-tus secondary to chronic pancreatitis. Pancreas 2000; 20:25-31.
41. Gullo L, Parenti M, Monti L, Pezzilli R Barbara L: Diabetic retinopathy in chronic pancreatitis. Gastroenterolog y 1990; 98: 1577- 1581.
42. Levitt NS, Adams G, Salmon J, Marks IN, Musson G, Swanepoel C, Levy M, Byrne MJ: The prevalence and severity of microvascu-lar complications in pancreatic diabetes and IDDM. Diabetes Care 1995; 18:971-974.
43. Davies M, Brophy S, Williams R, Taylor A: The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518-1522.
44. Ziegler O, Candiloros H, Guerci B, Got I, Crea T, Drouin P: Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabete Metab 1994; 20:540- 545.
45. Ito T, Kawabe K, Arita Y, Hisano T, Igarashi H, Funakoshi A, Sumii T, Yamanaka T, Takayanagi R: Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34:254-259.
46. Czakó L, Hegyközi É, Pálinkás A, Lonovics J: Autoimmune pancreatitis: functional and morphological recovery after steroid therapy. A case report. Word J Gastroenterol 2006; 12:1810-1812.
47. Nishimori I, Tamakoshi A, Kawa S, Tanaka S, Takeuchi K, Kamisawa T, Saisho H, Hira-no K, Okamura K, Yanagawa N, Otsuki M: Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nation-wide survey in Japan. Pancreas 2006; 32:244- 248.
48. Kamisawa T, Yoshiike M, Egawa N, Nakaji-ma H, Tsuruta K, Okamoto A: Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005; 5:234-238.
49. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Odawara M, Murase T, Hashimoto M, Watanabe G, Matsushita H, Inoko H, Takeuchi K: Corticosteroid- responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann NY Acad Sci 2002; 958: 152-159.
50. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
51. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of compli-cations in patients with type 2 diabetes (UK-PDS 33). Lancet 1998; 352: 837-853.
52. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-342.
53. American Diabetes Association: Standards of medical care in diabetes - 2007. Diabetes Care 2007;30(suppl 1):S4-S41.
54. Czakó L, Takács T, Hegyi P, Prónai L, Tulas-say Z, Lakner L, Döbrönte Z, Boda K, Lonov-ics J: Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003; 17: 597-603.
55. Domínguez-Muñoz JE: Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 116-122.
56. Starke AAR, Cupers HJ, Berger M: Therapeutic problems in diabetes secondary to pancreopathy; in Tiengo A, Alberti KGMM, Del Prato S, Vranic M (eds): Diabetes Secondary to Pancreopathy. Amsterdam, Ex-cerpta Medica, 1988, pp 227-233.
57. Tamás Gy: Insulinkezelés; in Halmos T, Jer-mendy Gy (eds): Diabetes Mellitus. Budapest, Elmélet és klinikum, Medicina, 2002, pp 305-336.
58. Creutzfeldt W, Gleichmann D, Otto J, Stock-mann F, Maisonneuve P, Lankisch PG: Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005; 72: 71-75.
59. Nomiyama Y, Tashiro M, Yamaguchi T, Watanabe S, Taguchi M, Asaumi H, Naka-mura H, Otsuki M: High glucose activates rat pancreatic stellate cells through protein kinase C and p38 mitogen-activated protein kinase pathway. Pancreas 2007; 3: 364-372.
60. Jalleh RP, Aslam M, Williamson RC: Pancreatic tissue and ductal pressures in chronic pancreatitis. Br J Surg 1991; 78: 1235-1237.
61. Schilling MK, Redaelli C, Reber PU, Friess H, Signer C, Stoupis C, Büchler MW: Micro-circulation in chronic alcoholic pancreatitis: a laser Doppler flow study. Pancreas 1999; 19: 21-25.
62. Watanabe S, Nagashio Y, Asaumi H, Nomi-yama Y, Taguchi M, Tashiro M, Kihara Y, Nakamura H, Otsuki M: Pressure activates rat pancreatic stellate cells. Am J Physiol 2004; 287:G1175-G1181.
63. Ewald N, Bretzel RG, Fantus IG, Hollenhorst M, Kloer HU, Hardt PD; S-2453110 Study Group: Pancreatin therapy in patients with insulin-treated diabetes mellitus and exo-crine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev 2007; 23:386-391.
64. Mohan V, Poongothai S, Pitchumoni CS: Oral pancreatic enzyme therapy in the control of diabete s mellitus in tropical calculous pancreatitis. Int J Pancreatol 1998; 24:19-22.
65. Hegyi P, Takacs T, Jarmay K, Nagy I, Czako L, Lonovics J: Spontaneous and cholecysto-kinin-octapeptide-promoted regeneration of the pancreas follow ing L -arginine-in-duced pancreatitis in rat. Int J Pancreatol 1997; 22:193-200.
66. Takacs T, Hegyi P, Jarmai K, Czako L, Gog Cs, Rakonczay Z Jr, Nemeth J, Lonovics J: CCK fails to promote pancreatic regeneration in diabetic rats following the induction of experimental pancreatitis. Pharm Res 2001; 44: 363-372.
67. Hegyi P, Takacs T, Tiszlavicz L, Czako L, Lo-novics J: Recovery of exocrine pancreas six months following pancreatitis induction with L -arginine in streptozotocin-diabetic rats. J Physiol Paris 2000; 94:51-55.
68. Balk MW, Lang CM, White WJ, Munger BL: Exocrine pancreatic dysfunction in guinea pigs with diabetes mellitus. Lab Invest 1975; 32:28-32.
69. Hegyi P, Czako L, Takacs T, Szilvassy Z, Lo-novics J: Pancreatic secretory responses in L-arginine-induced pancreatitis: comparison of diabetic and nondiabetic rats. Pancreas 1999; 19: 167-174.
70. Otsuki M, Goldfine ID, Williams JA: Diabetes in the rat is associated with a reversible post receptor defect in CCK action. Gastro-enterology 1984; 87:882-887.
71. Hegyi P, Rakonczay Z Jr, Sari R, Farkas N, Gog Cs, Németh J, Lonovics J, Takacs T: Insulin is necessary for the hypertrophic effect of CCK-8 following acute necrotizing experimental pancreatitis. World J Gastroenterol 2004; 10:2275-2277.
72. Lee KY, Zhou LU, Ren XS, Chang TM, Chey WY: An important role of endogenous insulin on exocrine pancreatic secretion in rats. Am J Physiol 1990; 258:G268-G274.